Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

5.20
-0.1000-1.89%
Volume:907.03K
Turnover:4.67M
Market Cap:281.80M
PE:4.30
High:5.31
Open:5.30
Low:5.04
Close:5.30
52wk High:7.54
52wk Low:3.93
Shares:54.19M
Float Shares:38.26M
Volume Ratio:0.77
T/O Rate:2.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.21
EPS(LYR):-1.5527
ROE:75.90%
ROA:-29.57%
PB:1.65
PE(LYR):-3.35

Loading ...

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Dec 01, 2025

Press Release: Abeona Therapeutics(R) Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones
·
Dec 01, 2025

Director Mark Alvino Reports Sale of Abeona Therapeutics Inc. Common Shares

Reuters
·
Nov 15, 2025

Optimistic Buy Rating for Abeona Therapeutics Amid Promising ZEVASKYN Outlook and Favorable Market Conditions

TIPRANKS
·
Nov 13, 2025

Abeona Therapeutics: Resilient Path to Profitability with Strong Market Demand and Strategic Optimizations

TIPRANKS
·
Nov 13, 2025

Abeona Therapeutics price target lowered to $19 from $20 at Stifel

TIPRANKS
·
Nov 13, 2025

Abeona Therapeutics Shares Soar on Higher Demand for Zevaskyn

Dow Jones
·
Nov 13, 2025

Abeona Therapeutics reports Q3 EPS (10c), consensus (34c)

TIPRANKS
·
Nov 12, 2025

Abeona Therapeutics sees cash runway for over two years

TIPRANKS
·
Nov 12, 2025

Abeona Therapeutics Q3 EPS $(0.10) Beats $(0.29) Estimate

Benzinga
·
Nov 12, 2025

Abeona Therapeutics Q3 EPS USD -0.1 VS. Ibes Estimate USD -0.29

THOMSON REUTERS
·
Nov 12, 2025

Abeona Therapeutics Q3 Income From Operations USD -24.018 Million VS. Ibes Estimate USD -18.2 Million

THOMSON REUTERS
·
Nov 12, 2025

Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates

GlobeNewswire
·
Nov 12, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12, 2025

Abeona Therapeutics (ABEO): Assessing Value After J-Code Milestone for ZEVASKYN Approval

Simply Wall St.
·
Nov 12, 2025

Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation

GlobeNewswire
·
Nov 07, 2025

Abeona Therapeutics Grants 71,035 Restricted Shares to New Employees

Reuters
·
Nov 03, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 03, 2025

BRIEF-Abeona Therapeutics Announces Permanent J-Code For Zevaskyn(Prademagene Zamikeracel)

Reuters
·
Oct 31, 2025

Abeona Therapeutics Inc - New J-Code J3389 for Zevaskyn Effective January 1, 2026

THOMSON REUTERS
·
Oct 30, 2025